|
2024
|
Invention
|
Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof.
The pre... |
|
|
Invention
|
Use of anti-fam19a5 antagonists for treating hearing disorders. The present disclosure relates to... |
|
2023
|
Invention
|
Use of galr2 agonists to treat gastrointestinal and/or endocrine disorders. The present disclosur... |
|
|
Invention
|
Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment of glaucom... |
|
|
Invention
|
Pharmaceutical use of fam19a5 involved in regulating gliogenesis.
The present invention relates ... |
|
|
Invention
|
Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment of neuropa... |
|
|
Invention
|
Anti-fam19a5 antibodies and uses thereof.
The present disclosure provides antibodies that specif... |
|
|
Invention
|
Use of anti-fam19a5 antibodies for treating cancers.
The present disclosure relates to the pharm... |
|
2022
|
Invention
|
Lrrc4 family mimic molecules and diagnostic uses thereof.
The present disclosure relates to the ... |
|
|
Invention
|
Lrrc4 family mimic molecules and diagnostic uses thereof. The present disclosure relates to the u... |
|
|
Invention
|
Inhibitors and uses thereof.
The present disclosure provides mimic molecules that are capable of... |
|
|
Invention
|
Inhibitors and uses thereof. The present disclosure provides mimic molecules that are capable of ... |
|
|
Invention
|
Polypeptide inhibitors and uses thereof. The present disclosure provides polypeptides that are ca... |
|
|
Invention
|
Anti-family with sequence similarity 19, member a5 antibodies and method of use thereof. The pres... |
|
|
Invention
|
Agonist of spexin-based galanin type 2 receptor and use thereof.
The present invention relates t... |
|
2021
|
Invention
|
Use of anti-fam19a5 antibodies for treating fibrosis. The present disclosure relates to the pharm... |
|
|
Invention
|
Use of anti-fam19a1 antagonists for treating central nervous system diseases.
The present disclo... |
|
|
Invention
|
Use of anti-fam19a1 antagonists for treating central nervous system diseases. The present disclos... |
|
2020
|
G/S
|
Research and development of medical apparatus and instruments for others; conducting clinical tri... |
|
|
G/S
|
Research and development of medical apparatus and
instruments for others; clinical trials; condu... |
|
|
Invention
|
Pharmaceutical use of fam19a5 involved in regulating gliogenesis. The present invention relates t... |
|
2019
|
Invention
|
Use of anti-fam19a5 antibodies for treating atherosclerosis.
The present disclosure relates to t... |
|
|
Invention
|
Use of anti-fam19a5 antibodies for treating atherosclerosis. (e.g.(e.g., an antibody or antigen-b... |
|
|
Invention
|
Use of anti-fam19a5 antibodies.
The present disclosure relates to the pharmaceutical use of anta... |
|
|
Invention
|
Use of anti-fam19a5 antibodies. The present disclosure relates to the pharmaceutical use of antag... |
|
|
Invention
|
Agonist of spexin-based galanin type 2 receptor and use thereof. The present invention relates to... |
|
|
Invention
|
Adeno-associated virus (aav) delivery of anti-fam19a5 antibodies. The present disclosure provides... |
|
|
Invention
|
Adeno-associated virus (aav) delivery of anti-fam19a5 antibodies. e.g.e.g.e.g., anti-FAM19A5 scFv. |
|
2018
|
Invention
|
Use of anti-family with sequence similarity 19, member a5 antibodies for the treatment and diagno... |
|
|
Invention
|
Anti-fam19a5 antibodies and uses thereof. The present disclosure provides antibodies that specifi... |
|
|
Invention
|
Use of anti-fam19a5 antibodies for treating cancers. The present disclosure relates to the pharma... |
